EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals

Sotirios Roussos iD, Georgios Papatheodoridis iD, Theodoros Angelopoulos iD, Evangelos Cholongitas iD, Nikolaos Papadopoulos iD, Spyridon Savvanis iD, Athina Chounta, Fani Pliarchopoulou, Panagiota Ioannidou iD, Melanie Deutsch iD, Maria-Vasiliki Papageorgiou iD, Spilios Manolakopoulos iD und 13 weitere

Journal of Viral Hepatitis · 2026-12 · 33 (12)

DOI: 10.1111/jvh.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 10.11.2026. Verfasst von Sotirios Roussos und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Antiviral Agents, Substance Abuse, Intravenous, Hepatitis C. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences Hellas, Gilead Sciences Europe Ltd, Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eliminating hepatitis C requires focusing efforts on people who inject drugs (PWID). The ARISTOTLE HCV‐HIV program aimed to increase HCV and HIV diagnosis and linkage to care among PWID, particularly those currently injecting and not linked to opioid agonist treatment (OAT). This study evaluated HCV diagnosis and linkage to direct‐acting antiviral (DAA) treatment before and after removal of fibrosis‐based treatment restrictions. ARISTOTLE HCV‐HIV (April 2018–February 2020) was conducted in a community setting at a fixed site in central Athens. Two respondent‐driven sampling rounds recruited PWID. Single‐visit procedures included interviews, blood collection, and liver fibrosis assessment. Reflex HCV‐RNA/HCV genotype testing was performed. Participants were linked to collaborating clinicians for DAA treatment. We estimated program reach by exploratory two‐source capture–recapture and constructed HCV care cascades. DAA initiation was assessed from the first visit documenting HCV monoinfection through 180 days after the last such visit. Among 1634 unique participants, 75.0% reported past‐30‐day injecting (exploratory model‐based reach among this population in Athens: 73.2%), 22.9% were currently receiving OAT, and 26.8% were currently homeless. Anti‐HCV prevalence was 76.9% (95% CI: 74.8–78.9), 83.3% (95% CI: 80.8–85.6) of anti‐HCV–positive individuals had viremia. Of 587 monoinfected individuals eligible for treatment, 43.4% initiated DAA. Lifting fibrosis restrictions boosted DAA utilization by 19.2 treatment courses/100 anti‐HCV–positive PWID. DAA access increased substantially after lifting liver fibrosis restrictions. Peer‐driven, community‐based interventions can achieve substantial program reach among underserved PWID and contribute to HCV elimination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSubstance Abuse, IntravenousHepatitis CHumansFemaleGreeceMaleAdultHepacivirusMiddle AgedDrug UsersYoung AdultHealth Services Accessibility

Stichwörter der Autor:innen

Cascade of caredirect‐acting antiviralshepatitis C virushuman immunodeficiency viruslinkage to carepeople who inject drugsrespondent‐driven sampling

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • 1st Department of Gastroenterology, General Hospital of Athens "Laiko", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases, Athens, Greece.
  • 1st Department of Internal Medicine, General Hospital of Athens "Laiko", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • 1st Department of Internal Medicine, 417 Army Share Fund Hospital of Athens, Athens, Greece.
  • Department of Internal Medicine, General Hospital of Athens "Elpis", Athens, Greece.

ORCID-Profile: Sotirios Roussos, Georgios Papatheodoridis, Theodoros Angelopoulos, Evangelos Cholongitas, Nikolaos Papadopoulos, Spyridon Savvanis, Panagiota Ioannidou, Melanie Deutsch, Maria-Vasiliki Papageorgiou, Spilios Manolakopoulos, Vasileios Sevastianos, Andreas Kapatais, Ioannis Vlachogiannakos, Maria Mela, Ioannis Elefsiniotis, Spyridon Vrakas, Dimitrios S Karagiannakis, Dimitrios Paraskevis, Mina Psichogiou, Angelos Hatzakis, Vana Sypsa

Förderung

  • Gilead Sciences Hellas
  • Gilead Sciences Europe Ltd
  • Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases
  • Abbvie Hellas
  • MSD Greece

Zitieren

APA

Roussos, S., Papatheodoridis, G., Angelopoulos, T., Cholongitas, E., Papadopoulos, N., Savvanis, S., Chounta, A., Pliarchopoulou, F., Ioannidou, P., Deutsch, M., Papageorgiou, M. V., Manolakopoulos, S., Sevastianos, V., Kapatais, A., Vlachogiannakos, I., Mela, M., Elefsiniotis, I., Vrakas, S., Karagiannakis, D. S., …, & Sypsa, V. (2026). Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals. Journal of Viral Hepatitis, 33(12). https://doi.org/10.1111/jvh.70252

Vancouver

Roussos S, Papatheodoridis G, Angelopoulos T, Cholongitas E, Papadopoulos N, Savvanis S, et al. Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals. Journal of Viral Hepatitis. 2026;33(12). doi:10.1111/jvh.70252

BibTeX
@article{Roussos2026,
  author = {Roussos, Sotirios and Papatheodoridis, Georgios and Angelopoulos, Theodoros and Cholongitas, Evangelos and Papadopoulos, Nikolaos and Savvanis, Spyridon and Chounta, Athina and Pliarchopoulou, Fani and Ioannidou, Panagiota and Deutsch, Melanie and Papageorgiou, Maria-Vasiliki and Manolakopoulos, Spilios and Sevastianos, Vasileios and Kapatais, Andreas and Vlachogiannakos, Ioannis and Mela, Maria and Elefsiniotis, Ioannis and Vrakas, Spyridon and Karagiannakis, Dimitrios S and Chaikalis, Savvas and Paraskevis, Dimitrios and Psichogiou, Mina and Kalamitsis, George and Hatzakis, Angelos and Sypsa, Vana},
  title = {Increasing HCV Diagnosis and Treatment Uptake Among Community‐Recruited People Who Inject Drugs in Athens, Greece, During the Transition to Unrestricted Access to Direct‐Acting Antivirals},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {12},
  doi = {10.1111/jvh.70252}
}
Kostenlos starten →